Page 326 - Vitamin D and Cancer
P. 326

13  Vitamin D and Colorectal Cancer                             313

              84. Moan J et al (2007) Colon cancer: prognosis for different latitudes, age groups and seasons in
               Norway. J Photochem Photobiol B 89(2–3):148–155
              85. Ng K et al (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with col-
               orectal cancer. J Clin Oncol 26(18):2984–2991
              86. Standing  Committee  on  the  Scientific  Evaluation  of  Dietary  Reference  Intakes  Food  and
               Nutrition Board Institute of Medicine (1999) Dietary reference intakes for calcium, phospho-
               rous, magnesium, vitamin D, and fluoride. Vitamin D. National Academy Press, Washington,
               DC, pp 250–287
              87. Heaney RP et al (2003) Human serum 25-hydroxycholecalciferol response to extended oral
               dosing with cholecalciferol. Am J Clin Nutr 77(1):204–210
              88. Bischoff-Ferrari  HA  et  al  (2006)  Estimation  of  optimal  serum  concentrations  of
               25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84(1):18–28
              89. Dawson-Hughes B, Bischoff-Ferrari HA (2007) Therapy of osteoporosis with calcium and
               vitamin D. J Bone Miner Res 22(Suppl 2):V59–V63
              90. Nesby-O’Dell S et al (2002) Hypovitaminosis D prevalence and determinants among African
               American  and  white  women  of  reproductive  age:  third  National  Health  and  Nutrition
               Examination Survey, 1988–1994. Am J Clin Nutr 76(1):187–192
              91. Vieth R, Chan PC, MacFarlane GD (2001) Efficacy and safety of vitamin D3 intake exceeding
               the lowest observed adverse effect level. Am J Clin Nutr 73(2):288–294
   321   322   323   324   325   326   327   328   329   330   331